Cargando…
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
BACKGROUND: In Australia two acellular Bordetella pertussis vaccines have replaced the use of a whole cell vaccine. Both of the licensed acellular vaccines contain the following three components; pertussis toxoid, pertussis filamentous haemagglutinin and the 69 kDa pertactin adhesin. One vaccine als...
Autores principales: | Byrne, Shane, Slack, Andrew T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459169/ https://www.ncbi.nlm.nih.gov/pubmed/16542440 http://dx.doi.org/10.1186/1471-2334-6-53 |
Ejemplares similares
-
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
por: Williams, Margaret M., et al.
Publicado: (2016) -
Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
por: Lam, Connie, et al.
Publicado: (2014) -
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
por: Ma, Longhuan, et al.
Publicado: (2021) -
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017
por: Xu, Zheng, et al.
Publicado: (2019) -
Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange
por: Buasri, Wasin, et al.
Publicado: (2012)